(ARBE) Arbe Robotics - Ratings and Ratios
Radar Chipset, Imaging Radar, Tx, Rx, Processor Chips
ARBE EPS (Earnings per Share)
ARBE Revenue
Description: ARBE Arbe Robotics
Arbe Robotics Ltd. is a semiconductor company specializing in 4D imaging radar solutions for various industries, including autonomous vehicles and commercial vehicles, with a global customer base. The companys product portfolio includes a radar chipset, Phoenix perception radar, and Lynx 4D imaging radar, designed for integration into advanced driver assistance systems (ADAS) and autonomous vehicles (AV) sensor suites.
To evaluate Arbe Robotics performance, we can examine key performance indicators (KPIs) such as revenue growth, gross margin, and operating expenses as a percentage of revenue. Given the companys focus on developing innovative radar solutions, its essential to monitor its research and development (R&D) expenses and their impact on future revenue streams. Additionally, we can analyze the companys cash burn rate and cash reserves to assess its ability to fund ongoing operations and invest in growth initiatives.
From a valuation perspective, we can consider metrics such as Enterprise Value (EV) to Revenue and EV to EBITDA (once the company becomes profitable). Arbe Robotics Market Cap of $184.24M USD and lack of P/E ratio indicate that the company is currently unprofitable, which is not uncommon for companies in the growth stage. To better understand the companys financial health, we can examine its cash flow statements and balance sheet to identify potential areas for improvement.
To assess the companys competitive position, we can analyze the market landscape for 4D imaging radar solutions and evaluate Arbe Robotics market share, customer acquisition costs, and customer retention rates. By examining these KPIs, we can gain a deeper understanding of Arbe Robotics strengths, weaknesses, and potential for long-term success.
ARBE Stock Overview
Market Cap in USD | 136m |
Sub-Industry | Application Software |
IPO / Inception | 2021-10-08 |
ARBE Stock Ratings
Growth Rating | -78.8% |
Fundamental | 27.0% |
Dividend Rating | - |
Return 12m vs S&P 500 | -39.0% |
Analyst Rating | 4.0 of 5 |
ARBE Dividends
Currently no dividends paidARBE Growth Ratios
Growth Correlation 3m | -75.9% |
Growth Correlation 12m | -62.9% |
Growth Correlation 5y | -94.3% |
CAGR 5y | -40.00% |
CAGR/Max DD 3y | -0.46 |
CAGR/Mean DD 3y | -0.56 |
Sharpe Ratio 12m | -0.04 |
Alpha | 0.32 |
Beta | 0.739 |
Volatility | 109.24% |
Current Volume | 1428k |
Average Volume 20d | 947.7k |
Stop Loss | 1.3 (-8.5%) |
Signal | -0.23 |
Piotroski VR‑10 (Strict, 0-10) 0.5
Net Income (-48.7m TTM) > 0 and > 6% of Revenue (6% = 32.2k TTM) |
FCFTA -0.44 (>2.0%) and ΔFCFTA 9.64pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 3990 % (prev 1771 %; Δ 2219 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA -0.45 (>3.0%) and CFO -34.0m > Net Income -48.7m (YES >=105%, WARN >=100%) |
NO Net Debt/EBITDA fails (EBITDA <= 0) |
Current Ratio 2.34 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (112.2m) change vs 12m ago 43.43% (target <= -2.0% for YES) |
Gross Margin -179.7% (prev -27.62%; Δ -152.0pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 0.77% (prev 2.17%; Δ -1.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio -85.83 (EBITDA TTM -49.6m / Interest Expense TTM 584.0k) >= 6 (WARN >= 3) |
Altman Z'' -31.19
(A) 0.28 = (Total Current Assets 37.4m - Total Current Liabilities 16.0m) / Total Assets 75.8m |
(B) -3.65 = Retained Earnings (Balance) -276.9m / Total Assets 75.8m |
warn (B) unusual magnitude: -3.65 — check mapping/units |
(C) -0.72 = EBIT TTM -50.1m / Avg Total Assets 69.6m |
(D) -15.51 = Book Value of Equity -276.9m / Total Liabilities 17.9m |
Total Rating: -31.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 27.03
1. Piotroski 0.50pt = -4.50 |
2. FCF Yield -27.23% = -5.0 |
3. FCF Margin data missing |
4. Debt/Equity 0.20 = 2.48 |
5. Debt/Ebitda -0.24 = -2.50 |
6. ROIC - WACC (= -90.77)% = -12.50 |
7. RoE -119.3% = -2.50 |
8. Rev. Trend -34.38% = -2.58 |
9. EPS Trend 82.50% = 4.12 |
What is the price of ARBE shares?
Over the past week, the price has changed by +9.23%, over one month by +10.08%, over three months by -9.55% and over the past year by -27.55%.
Is Arbe Robotics a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ARBE is around 0.86 USD . This means that ARBE is currently overvalued and has a potential downside of -39.44%.
Is ARBE a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ARBE price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 1.9 | 32.4% |
Analysts Target Price | 1.9 | 32.4% |
ValueRay Target Price | 1 | -33.1% |
Last update: 2025-09-05 04:32
ARBE Fundamental Data Overview
CCE Cash And Equivalents = 26.0m USD (Cash And Short Term Investments, last quarter)
P/S = 253.4188
P/B = 2.3425
Beta = 0.423
Revenue TTM = 536.0k USD
EBIT TTM = -50.1m USD
EBITDA TTM = -49.6m USD
Long Term Debt = 1.85m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 10.00m USD (from shortTermDebt, last quarter)
Debt = 11.8m USD (Calculated: Short Term 10.00m + Long Term 1.85m)
Net Debt = 4.83m USD (from netDebt column, last quarter)
Enterprise Value = 121.6m USD (135.8m + Debt 11.8m - CCE 26.0m)
Interest Coverage Ratio = -85.83 (Ebit TTM -50.1m / Interest Expense TTM 584.0k)
FCF Yield = -27.23% (FCF TTM -33.1m / Enterprise Value 121.6m)
FCF Margin = -6180 % (FCF TTM -33.1m / Revenue TTM 536.0k)
Net Margin = -9094 % (Net Income TTM -48.7m / Revenue TTM 536.0k)
Gross Margin = -179.7% ((Revenue TTM 536.0k - Cost of Revenue TTM 1.50m) / Revenue TTM)
Tobins Q-Ratio = -0.44 (set to none) (Enterprise Value 121.6m / Book Value Of Equity -276.9m)
Interest Expense / Debt = 3.86% (Interest Expense 457.0k / Debt 11.8m)
Taxrate = 21.0% (US default)
NOPAT = -50.1m (EBIT -50.1m, no tax applied on loss)
Current Ratio = 2.34 (Total Current Assets 37.4m / Total Current Liabilities 16.0m)
Debt / Equity = 0.20 (Debt 11.8m / last Quarter total Stockholder Equity 58.0m)
Debt / EBITDA = -0.24 (Net Debt 4.83m / EBITDA -49.6m)
Debt / FCF = -0.36 (Debt 11.8m / FCF TTM -33.1m)
Total Stockholder Equity = 40.9m (last 4 quarters mean)
RoA = -64.28% (Net Income -48.7m, Total Assets 75.8m )
RoE = -119.3% (Net Income TTM -48.7m / Total Stockholder Equity 40.9m)
RoCE = -117.4% (set to none) (Ebit -50.1m / (Equity 40.9m + L.T.Debt 1.85m))
RoIC = -82.49% (NOPAT -50.1m / Invested Capital 60.8m)
WACC = 8.28% (E(135.8m)/V(147.7m) * Re(8.74%)) + (D(11.8m)/V(147.7m) * Rd(3.86%) * (1-Tc(0.21)))
Shares Correlation 3-Years: 100.00 | Cagr: 5.29%
Discount Rate = 8.74% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -33.1m)
EPS Correlation: 82.50 | EPS CAGR: 27.54% | SUE: 1.56 | # QB: 2
Revenue Correlation: -34.38 | Revenue CAGR: 24.80% | SUE: N/A | # QB: None
Additional Sources for ARBE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle